BCL2L14

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, BCL2L14 mutation is significantly associated with the RNA expression of many other genes, with 966 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible BCL2L14-associated genes across cancer lineages are KLC2, SDHA, and PDRG1. Each is linked with BCL2L14 in more than 1 cancer types. Because this analysis shows association rather than direction, both BCL2L14-to-partner and partner-to-BCL2L14 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, KLC2 grouped by BCL2L14-low versus BCL2L14-high in UCEC.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (BCL2L14→partner) and Y-score (partner→BCL2L14) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
UCECKLC2 →+0.418+3.467.008.00232
UCECSDHA →+0.704+2.625<.001.00532
UCECPDRG1 →+0.531+3.459.002.00532
BRCAUBE2V1P8 →+0.193+6.571<.001.00132
UCECRPS29P32 →+0.515+2.462<.001.00432
HNSCRNA5SP424 →+0.310+6.468<.001.00132
Each partner links to its Q-omics profile. Showing the 6 strongest of 966 associations by consensus.

KLC2 by BCL2L14 expression — UCEC

Box plot of KLC2 in BCL2L14-low vs BCL2L14-high samples in UCEC.

Explore this box plot interactively →

Exploration